{"acquired gene mutation": 26.56, "acute graft versus host disease": 11.72, "acute hepatic failure": 9.56, "acute myeloid leukaemia": 14.71, "acute promyelocytic leukaemia": 25.33, "agranulocytosis": 11.29, "anaemia": 3.43, "anti-muellerian hormone level decreased": 567.09, "aplastic anaemia": 7.48, "b-cell lymphoma": 14.46, "b-cell lymphoma recurrent": 137.65, "bacteraemia": 7.15, "blood follicle stimulating hormone increased": 126.88, "blood lactate dehydrogenase increased": 4.16, "blood luteinising hormone increased": 198.63, "bone marrow failure": 6.37, "bronchopulmonary aspergillosis": 5.77, "cardiac failure": 3.09, "cardiomyopathy": 9.46, "cardiotoxicity": 29.11, "central nervous system lymphoma": 46.16, "chemotherapy": 26.9, "clostridium difficile infection": 2.68, "congenital aplasia": 13.89, "cytokine release syndrome": 2.41, "cytopenia": 16.84, "diffuse large b-cell lymphoma": 34.58, "diffuse large b-cell lymphoma recurrent": 161.47, "diffuse large b-cell lymphoma refractory": 72.23, "dilated cardiomyopathy": 5.6, "disease progression": 9.17, "drug resistance": 2.82, "ejection fraction decreased": 6.07, "epstein-barr virus infection reactivation": 37.75, "febrile bone marrow aplasia": 15.99, "febrile neutropenia": 43.78, "follicular lymphoma": 59.49, "granulocyte count decreased": 35.03, "granulocytopenia": 19.42, "haematotoxicity": 7.98, "haemoglobin decreased": 2.87, "haemophagocytic lymphohistiocytosis": 4.06, "hepatic failure": 2.62, "hepatic function abnormal": 3.57, "hepatitis b": 21.96, "hepatitis b reactivation": 57.82, "hodgkin's disease recurrent": 160.67, "hormone level abnormal": 10.79, "immune-mediated adrenal insufficiency": 14.56, "inappropriate antidiuretic hormone secretion": 2.72, "infection": 3.27, "intentional product use issue": 2.22, "interstitial lung disease": 10.23, "left ventricular dysfunction": 6.72, "leukopenia": 8.04, "liver injury": 2.04, "lymphocyte count decreased": 6.15, "lymphoma": 2.55, "lymphopenia": 4.16, "mucosal inflammation": 7.06, "myelodysplastic syndrome": 11.18, "myelosuppression": 44.51, "neoplasm progression": 5.49, "neuropathy peripheral": 2.95, "neutropenia": 9.13, "neutropenic sepsis": 20.88, "neutrophil count decreased": 24.98, "no adverse event": 2.5, "non-hodgkin's lymphoma": 6.21, "oestradiol decreased": 277.02, "off label use": 3.68, "palmar-plantar erythrodysaesthesia syndrome": 2.06, "pancytopenia": 7.85, "platelet count decreased": 5.9, "pleural effusion": 2.32, "pneumocystis jirovecii pneumonia": 20.98, "pneumonia": 2.5, "pneumonitis": 3.03, "premature baby": 4.69, "premature labour": 8.94, "product use in unapproved indication": 9.17, "progressive multifocal leukoencephalopathy": 18.74, "pulmonary toxicity": 4.67, "red blood cell count decreased": 3.15, "second primary maligcy": 38.16, "sepsis": 5.02, "septic shock": 5.65, "stomatitis": 3.47, "therapy partial responder": 8.27, "thrombocytopenia": 3.55, "transaminases increased": 2.26, "tumour lysis syndrome": 19.87, "venoocclusive liver disease": 10.04, "white blood cell count decreased": 17.69}